We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Telstar Promotes Latest Generation of Freeze Dryers in Dubai

By LabMedica International staff writers
Posted on 31 Jan 2019
Telstar (Shanghai, China) displayed the latest generation of compact laboratory freeze dryers at MedLab Middle East 2019 held in Dubai, UAE, from February 4-7, 2019. More...
The event saw more than 19,610 unique visitors and 678+ exhibitors sharing the most recent technology available in the IVD, and medical laboratory market.

Among its products exhibited at MedLab Middle East 2019 was the Telstar LyoQuest, a bench-top laboratory freeze dryer that combines this breadth of functionality into a single unit so that users can perform complete cycles on a range of sample containers (vials, trays, ampoules, and flasks) using the same piece of equipment. LyoQuest also enables users to create recipes comprising time, temperature and vacuum control via its integrated PLC control system. Its innovative design results in an extremely compact unit with large condensation capacity up to eight liters and enables many product formats to be pre-frozen by the device, without the need for an additional freezer. The LyoQuest’s ice condenser includes an automatic defrosting function for quick and easy de-icing.

The company also promoted the Telstar Bio II Advance Plus compact range of microbiological safety cabinets (MSC) that are intended for the laminar flow manipulation of microorganisms with biological risk levels 2 and 3. Their innovative cabinet design offers smaller body than the market average while maintaining standard workspace. With dimensions of 759 mm in width and 1260 mm in height, the Bio II Advance Plus provides a working volume of 340 dm3. Equipped to achieve maximum efficiency, this new range of MSC integrates energy saving EC fans and LED illumination that ensures optimum protection levels as well as low energy consumption. Bio II Advance Plus is designed in compliance with the European standards EN 12469 and certified by TÜV-Nord.

Telstar also displayed Boreas, a new -86º ultra-low-temperature freezer designed to increase average performance by 20% and featuring an innovative mechanical design that enhances robustness, efficiency and ergonomics as well as ensures the integrity of the cold preservation process. Equipped with vacuum panels VIP, the freezer guarantees the highest level of thermal insulation and a temperature of -80ºC under an ambient up to +28ºC. Unlike standard freezers designed with panels based on polyurethane foam, a thinner inner insulation provides Boreas with an enlarged storage capacity of up to 30%. Boreas uses high purity natural refrigerant gases to contribute to environment preservation and does not damage the ozone layer. The ecological ultra-low-freezers line has been developed using Telstar’s in-house cold storage technology.


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Whole Blood Control
Lyphochek Whole Blood Control
New
Francisella Tularensis Test
TULAREMIA VIRCLIA IgG+IgM MONOTEST
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.